Related Experiment Video
Updated: Oct 4, 2025

07:37
Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids
Published on: August 16, 2024
1.6K
Human artificial oocytes from patients' somatic cells: past, present and future
Jan Tesarik1, Carmen Mendoza2, Raquel Mendoza-Tesarik1
1MARGen Clinic, Granada, Spain.
Reproduction & Fertility
|February 7, 2022
Summary
Creating artificial oocytes from a patient's own DNA offers hope for genetically related children. Research continues to overcome challenges in reprogramming somatic cells for successful oogenesis and development.
Area of Science:
- Reproductive biology
- Stem cell science
- Genetics
Background:
- Generating functional human oocytes from somatic cells has been explored since the early 2000s.
- Early attempts using somatic cell nuclear transfer showed promise but were halted due to adverse outcomes in mouse models.
- Induced pluripotent stem (iPS) cells, successful in mice, failed to progress beyond the oogonium stage in humans.
Purpose of the Study:
- To review strategies for generating artificial oocytes for women lacking healthy oocytes.
- To explore the potential of using a patient's own somatic cells for creating genetically related offspring.
- To discuss the challenges and future directions in artificial oocyte generation.
Main Methods:
- Review of historical attempts at somatic cell nuclear transfer for oocyte generation.
- Analysis of induced pluripotent stem cell-based oogenesis in human and animal models.
- Discussion of the dual requirements for DNA haploidization and reprogramming of somatic cells.
Main Results:
- Somatic cell nuclear transfer in humans requires further investigation due to past issues in mouse models.
- Human iPS cell-derived oogenesis does not advance beyond the oogonium stage.
- Enucleated donor oocytes may be necessary for creating fertilizable human oocytes from somatic DNA.
Conclusions:
- Artificial oocytes derived from a patient's own somatic cells represent a crucial option for fertility.
- Overcoming challenges in DNA reprogramming and haploidization is essential for successful artificial oocyte development.
- Further research is needed to optimize strategies for generating viable human oocytes from somatic cells.
Related Concept Videos
Stem Cell Culture
5.6K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.6K
Embryonic Stem Cells
3.8K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
3.8K
Oogenesis
64.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
64.7K
Methods of Nuclear Reprogramming
1.9K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.9K
Induced Pluripotent Stem Cells
4.5K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.5K
iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K

